Technical Analysis for TBIO - Translate Bio, Inc.

Grade Last Price % Change Price Change
D 22.44 9.36% 1.92
TBIO closed up 3.74 percent on Wednesday, April 21, 2021, on 62 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical TBIO trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 9.36%
Multiple of Ten Bullish Other 9.36%
Outside Day Range Expansion 9.36%
Wide Bands Range Expansion 9.36%
Above Upper BB Strength 9.36%
Overbought Stochastic Strength 9.36%
Up 3 Days in a Row Strength 9.36%
Upper Bollinger Band Touch Strength 9.36%
Pocket Pivot Bullish Swing Setup 13.45%
Upper Bollinger Band Walk Strength 13.45%
Older End-of-Day Signals for TBIO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 1 hour ago
Trending on StockTwits about 3 hours ago
Up 1 ATR about 3 hours ago
Up 5% about 4 hours ago
Rose Above 50 DMA about 5 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. It has a collaboration and license agreement with Sanofi Pasteur Inc. to develop mRNA vaccines for up to five infectious disease pathogens, as well as against COVID-19. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Diseases Dysfunction Cystic Fibrosis Infectious Disease Cac 40 Messenger RNA Treatment Of Cystic Fibrosis Arcturus Therapeutics Urea Cycle

Is TBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.64
52 Week Low 10.22
Average Volume 1,222,298
200-Day Moving Average 18.61
50-Day Moving Average 21.08
20-Day Moving Average 17.53
10-Day Moving Average 18.54
Average True Range 1.22
ADX 20.46
+DI 26.46
-DI 17.22
Chandelier Exit (Long, 3 ATRs ) 16.86
Chandelier Exit (Short, 3 ATRs ) 19.11
Upper Bollinger Band 20.23
Lower Bollinger Band 14.84
Percent B (%b) 1.05
BandWidth 30.76
MACD Line -0.22
MACD Signal Line -0.84
MACD Histogram 0.6209
Fundamentals Value
Market Cap 1.53 Billion
Num Shares 74.3 Million
EPS -2.40
Price-to-Earnings (P/E) Ratio -8.57
Price-to-Sales 13.54
Price-to-Book 3.93
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.80
Resistance 3 (R3) 22.55 21.54 22.42
Resistance 2 (R2) 21.54 20.96 21.67 22.29
Resistance 1 (R1) 21.03 20.60 21.29 21.28 22.17
Pivot Point 20.02 20.02 20.15 20.15 20.02
Support 1 (S1) 19.51 19.44 19.77 19.76 18.87
Support 2 (S2) 18.50 19.08 18.63 18.75
Support 3 (S3) 17.99 18.50 18.62
Support 4 (S4) 18.24